TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover |
11,284
|
11,484 | |
Financial expenses |
0
|
1 | |
Earnings before taxes |
302
|
158 | |
EBITDA |
310
|
174 | |
Total assets |
4,477
|
4,662 | |
Current assets |
4,450
|
4,627 | |
Current liabilities |
1,249
|
1,600 | |
Equity capital |
3,007
|
2,845 | |
- share capital |
48
|
49 | |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency |
67.2%
|
61.0% | |
Turnover per employee |
3,761
|
3,828 | |
Profit as a percentage of turnover |
2.7%
|
1.4% | |
Return on assets (ROA) |
6.7%
|
3.4% | |
Current ratio |
356.3%
|
289.2% | |
Return on equity (ROE) |
10.0%
|
5.6% | |
Change turnover |
98
|
160 | |
Change turnover % |
7%
|
1%
![]() |
1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.